Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Receives $13.46 Average PT from Analysts

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has been given a consensus rating of “Reduce” by the fourteen research firms that are presently covering the stock, MarketBeat Ratings reports. Four analysts have rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $13.46.

WBA has been the subject of several recent analyst reports. Bank of America lowered their price target on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a report on Wednesday, September 4th. Royal Bank of Canada decreased their price target on Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a report on Tuesday, July 2nd. Truist Financial dropped their price objective on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research note on Monday, October 7th. TD Cowen decreased their target price on shares of Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating for the company in a research note on Thursday, September 12th. Finally, Morgan Stanley cut their price objective on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a report on Friday, October 11th.

Hedge Funds Weigh In On Walgreens Boots Alliance

A number of institutional investors have recently bought and sold shares of WBA. Capital World Investors lifted its stake in Walgreens Boots Alliance by 57.5% during the first quarter. Capital World Investors now owns 29,061,021 shares of the pharmacy operator’s stock worth $630,334,000 after purchasing an additional 10,612,373 shares in the last quarter. Thompson Siegel & Walmsley LLC lifted its stake in Walgreens Boots Alliance by 98.8% during the 2nd quarter. Thompson Siegel & Walmsley LLC now owns 6,021,126 shares of the pharmacy operator’s stock worth $72,826,000 after acquiring an additional 2,992,648 shares in the last quarter. Newport Trust Company LLC acquired a new position in Walgreens Boots Alliance during the 2nd quarter worth about $31,028,000. Swedbank AB acquired a new position in Walgreens Boots Alliance in the 1st quarter valued at about $16,365,000. Finally, Minneapolis Portfolio Management Group LLC purchased a new stake in Walgreens Boots Alliance during the first quarter worth about $13,710,000. 58.59% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Trading Up 15.8 %

Shares of NASDAQ WBA opened at $10.42 on Friday. Walgreens Boots Alliance has a 1-year low of $8.22 and a 1-year high of $27.05. The business has a fifty day moving average price of $9.40 and a 200 day moving average price of $13.23. The stock has a market capitalization of $9.00 billion, a P/E ratio of -1.55, a price-to-earnings-growth ratio of 1.04 and a beta of 0.70. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.65 and a quick ratio of 0.31.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.